|
1
|
Noone A, Howlader N, Krapcho M, Miller D,
Brest A and Yu M: SEER cancer statistics review, 1975–2015, based
on November 2017 SEER data submission, posted to the SEER website,
April 2018.
|
|
2
|
Scott RH, Stiller CA, Walker L and Rahman
N: Syndromes and constitutional chromosomal abnormalities
associated with Wilms tumour. J Med Genet. 43:705–715. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dome JS, Graf N, Geller JI, Fernandez CV,
Mullen EA, Spreafico F, Van den Heuvel-Eibrink M and
Pritchard-Jones K: Advances in Wilms tumor treatment and biology:
Progress through international collaboration. J Clin Oncol.
33:2999–3007. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
D'Angelo P, Di Cataldo A, Terenziani M,
Bisogno G, Collini P, Di Martino M, Melchionda F, Mosa C, Nantron
M, Perotti D, et al: Factors possibly affecting prognosis in
children with Wilms' tumor diagnosed before 24 months of age: A
report from the Associazione Italiana Ematologia Oncologia
Pediatrica (AIEOP) Wilms tumor working group. Pediatr Blood Cancer.
642017.doi: 10.1002/pbc.26644. PubMed/NCBI
|
|
5
|
Bernstein L, Linet M and Smith M: Renal
tumorsNational Cancer Institute, SEER Program. Bethesda, MD:
National Institutes of Health; pp. 79–90. 1999
|
|
6
|
Mitchell C, Pritchard-Jones K, Shannon R,
Hutton C, Stevens S, Machin D, Imeson J, Kelsey A, Vujanic GM,
Gornall P, et al: Immediate nephrectomy versus preoperative
chemotherapy in the management of non-metastatic Wilms' tumour:
Results of a randomised trial (UKW3) by the UK Children's Cancer
Study Group. Eur J Cancer. 42:2554–2562. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Malogolowkin M, Spreafico F, Dome JS, van
Tinteren H, Pritchard-Jones K, van den Heuvel-Eibrink MM, Bergeron
C, de Kraker J and Graf N; COG Renal Tumors Committee and the SIOP
Renal Tumor Study Group, : Incidence and outcomes of patients with
late recurrence of Wilms' tumor. Pediatr Blood Cancer. 6:1612–1615.
2013. View Article : Google Scholar
|
|
8
|
Venkatramani R, Chi YY, Coppes MJ,
Malogolowkin M, Kalapurakal JA, Tian J and Dome JS: Outcome of
patients with intracranial relapse enrolled on national Wilms tumor
study group clinical trials. Pediatr Blood Cancer. 642017.doi:
10.1002/pbc.26406. PubMed/NCBI
|
|
9
|
Clark MB, Johnston RL, Inostroza-Ponta M,
Fox AH, Fortini E, Moscato P, Dinger ME and Mattick JS: Genome-wide
analysis of long noncoding RNA stability. Genome Res. 22:885–898.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tani H, Imamachi N, Mizutani R, Imamura K,
Kwon Y, Miyazaki S, Maekawa S, Suzuki Y and Akimitsu N: Genome-wide
analysis of long noncoding RNA turnover. Methods Mol Biol.
1262:305–320. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Carpenter S: Long noncoding RNA: Novel
links between gene expression and innate immunity. Virus Res.
212:137–145. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li CH and Chen Y: Insight into the role of
long noncoding RNA in cancer development and progression. Int Rev
Cell Mol Biol. 326:33–65. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moran VA, Perera RJ and Khalil AM:
Emerging functional and mechanistic paradigms of mammalian long
non-coding RNAs. Nucleic Acids Res. 40:6391–6400. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dong X, Chen R, Lin H, Lin T and Pan S:
LncRNA BG981369 inhibits cell proliferation, migration, and
invasion, and promotes cell apoptosis by SRY-related high-mobility
group box 4 (SOX4) signaling pathway in human gastric cancer. Med
Sci Monit. 24:718–726. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lian Y, Xiao C, Yan C, Chen D, Huang Q,
Fan Y, Li Z and Xu H: Knockdown of pseudogene derived from LncRNA
DUXAP10 inhibits cell proliferation, migration, invasion, and
promotes apoptosis in pancreatic cancer. J Cell Biochem.
119:3671–3682. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin MT, Song HJ and Ding XY: Long
non-coding RNAs involved in metastasis of gastric cancer. World J
Gastroenterol. 24:3724–3737. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rönnau CG, Verhaegh GW, Luna-Velez MV and
Schalken JA: Noncoding RNAs as novel biomarkers in prostate cancer.
Biomed Res Int. 2014:5917032014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhu KR, Sun QF and Zhang YQ: Long
non-coding RNA LINP1 induces tumorigenesis of Wilms' tumor by
affecting Wnt/β-catenin signaling pathway. Eur Rev Med Pharmacol
Sci. 23:5691–5698. 2019.PubMed/NCBI
|
|
19
|
R Core Team, . A language and environment
for statistical computingVienna, Austria: R Foundation for
Statistical Computing; 2014
|
|
20
|
Rivera MN and Haber DA: Wilms' tumour:
Connecting tumorigenesis and organ development in the kidney. Nat
Rev Cancer. 5:699–712. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hamilton TE and Shamberger RC: Wilms
tumor: Recent advances in clinical care and biology. Semin Pediatr
Surg. 21:15–20. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Irtan S, Ehrlich PF and Pritchard-Jones K:
Wilms tumor: ‘State-of-the-art’ update, 2016. Semin Pediatr Surg.
25:250–256. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nakayama DK and Bonasso PC: The history of
multimodal treatment of Wilms' tumor. Am Surg. 82:487–492.
2016.PubMed/NCBI
|
|
24
|
Zhu S, Fu W, Zhang L, Fu K, Hu J, Jia W
and Liu G: LINC00473 antagonizes the tumour suppressor miR-195 to
mediate the pathogenesis of Wilms tumour via IKKα. Cell Prolif.
512018.doi: 10.1111/cpr.12416.
|
|
25
|
Mitra SA, Mitra AP and Triche TJ: A
central role for long non-coding RNA in cancer. Front Genet.
3:172012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Prensner JR and Chinnaiyan AM: The
emergence of lncRNAs in cancer biology. Cancer Discov. 1:391–407.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Martens-Uzunova ES, Böttcher R, Croce CM,
Jenster G, Visakorpi T and Calin GA: Long noncoding RNA in
prostate, bladder, and kidney cancer. Eur Urol. 65:1140–1151. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang M, Zhou L, Yu F, Zhang Y, Li P and
Wang K: The functional roles of exosomal long non-coding RNAs in
cancer. Cell Mol Life Sci. 76:2059–2076. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
de Fatima Silva F, Ortiz-Silva M, Galia
WBS, Cassolla P, de Silva FG, Graciano MFR, Carpinelli AR and de
Souza HM: Effects of metformin on insulin resistance and metabolic
disorders in tumor-bearing rats with advanced cachexia. Can J
Physiol Pharmacol. 96:498–505. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hage-Sleiman R, Herveau S, Matera EL,
Laurier JF and Dumontet C: Tubulin binding cofactor C (TBCC)
suppresses tumor growth and enhances chemosensitivity in human
breast cancer cells. BMC Cancer. 10:1352010. View Article : Google Scholar : PubMed/NCBI
|
